Corrigendum to ‘Multicenter phase II study of trastuzumab in combination with capecitabine and oxaliplatin for advanced gastric cancer’, [Eur J Canc 51 (2015) 482–488]

Abstract

The authors regret that the dosage details for trastuzumab in the original publication were incorrectly given as 8 and 6 mg/m2. The correct dosage for trastuzumab should be 8 and 6 mg/kg. The online article has been updated accordingly. The authors would like to apologise for any inconvenience caused.